In recent trading session, Kezar Life Sciences Inc (NASDAQ:KZR) saw 0.51 million shares changing hands at last check today with its beta currently measuring 0.21. Company’s recent per share price level of $0.80 trading at -$0.09 or -11.05% at last check today assigns it a market valuation of $58.06M. That most recent trading price of KZR’s stock is at a discount of -41.25% from its 52-week high price of $1.13 and is indicating a premium of 35.0% from its 52-week low price of $0.52. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.58 million shares which gives us an average trading volume of 829.15K if we extend that period to 3-months.

For Kezar Life Sciences Inc (KZR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.33. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.31 in the current quarter.

Kezar Life Sciences Inc (NASDAQ:KZR) trade information

Upright in the red during last session for losing -11.05%, in the last five days KZR remained trading in the red while hitting it’s week-highest on Wednesday, 10/16/24 when the stock touched $0.80 price level, adding 10.58% to its value on the day. Kezar Life Sciences Inc’s shares saw a change of -16.00% in year-to-date performance and have moved -6.77% in past 5-day. Kezar Life Sciences Inc (NASDAQ:KZR) showed a performance of 38.06% in past 30-days. Number of shares sold short was 0.98 million shares which calculate 0.92 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 17.5 to the stock, which implies a rise of 95.43% to its recent value today. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 21. It follows that stock’s current price would drop -1650.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1650.0% for stock’s current value.

Kezar Life Sciences Inc (KZR) estimates and forecasts

Statistics highlight that Kezar Life Sciences Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 1.04% of value to its shares in past 6 months, showing an annual growth rate of 8.40% while that of industry is 17.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -71.40% from the last financial year’s standing.

5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 800k for the same. And 5 analysts are in estimates of company making revenue of 1.6M in the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 9.06% during past 5 years.

Kezar Life Sciences Inc (NASDAQ:KZR)’s Major holders

Insiders are in possession of 14.79% of company’s total shares while institution are holding 63.95 percent of that, with stock having share float percentage of 75.05%. Investors also watch the number of corporate investors in a company very closely, which is 63.95% institutions for Kezar Life Sciences Inc that are currently holding shares of the company. SUVRETTA CAPITAL MANAGEMENT, LLC is the top institutional holder at KZR for having 7.17 million shares of worth $4.3 million. And as of 2024-06-30, it was holding 9.8456 of the company’s outstanding shares.

The second largest institutional holder is AVIDITY PARTNERS MANAGEMENT LP, which was holding about 5.03 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.9039 of outstanding shares, having a total worth of $3.02 million.